It's My Life
It's My Life It's My Life Hemophilia Village
Information for Health Care Professionals
Product Information Indication/Safety Information Tell a Friend Site Map
It's My Life

Home
About Hemophilia
Programs & Services
Treating Hemophilia
About BeneFIX
About ReFacto
Personal Stories
News & Resources
News
News Archive
Events Calendar
Online Resources
Publications
Wyeth & Hemophilia
Wyeth
 News

 

Second BeneFIX Manufacturing Facility Receives Regulatory Approval

May 2004

Wyeth is pleased to announce that the U.S. Food and Drug Administration has approved our application to manufacture BeneFIX® Coagulation Factor IX (Recombinant) at a manufacturing facility in Conshohocken, Pennsylvania.

The addition of the Conshohocken facility will increase the capacity to produce BeneFIX by more than 50 percent and represents the Wyeth commitment to meet the future needs of the worldwide hemophilia B community. BeneFIX is also produced at the Wyeth manufacturing facility in Andover, Massachusetts.

Wyeth remains committed to providing safe and effective recombinant factor products with enhanced viral safety, supporting individualized tailored care for the hemophilia community, and improving the lives of hemophilia patients around the world.

Back to News



108131-02

    
Privacy Policy | Terms and Conditions
The information on this site is only intended for residents of the United States.
© 2007, Wyeth Pharmaceuticals Inc., Philadelphia, PA 19101
119533-01